12 de Octubre University Hospital, Madrid, Spain.
Compr Psychiatry. 2012 Nov;53(8):1063-70. doi: 10.1016/j.comppsych.2012.04.013. Epub 2012 Jun 6.
The study aims to identify psychopathologic variables in cannabis-induced psychosis and recent-onset primary psychoses using the Symptom Checklist-90-R and the Psychiatric Research Interview for Substance and Mental Disorders. A sample of 181 subjects with psychotic symptoms and cannabis use referred to the psychiatry inpatient units of 3 university general hospitals were assessed. The final sample included 50 subjects with a diagnosis of cannabis-induced psychotic disorder (CIPD) and 104 subjects with primary psychotic disorders. Using receiver operating characteristic curves, the most efficient psychopathologic variables for classifying CIPD were interpersonal sensitivity, "depression," phobic anxiety, and Scale to Assess Unawareness of Mental Disorders subscales. The area under the receiver operating characteristic curve of the model including depression and "misattribution" scores was 96.78% (95% confidence interval, 94.43-99.13). Depressive symptoms could be used to distinguish CIPD from other primary psychotic disorders. Clinical variables related to "neurotic" symptoms could be involved in the susceptibility to cannabis-induced psychosis.
本研究旨在使用症状清单-90-R 和精神障碍和物质使用精神病学研究访谈来确定大麻引起的精神病和近期首发精神病中的精神病理学变量。对 3 所大学综合医院的精神病住院患者中出现精神病症状和大麻使用的 181 名受试者进行了评估。最终样本包括 50 名大麻引起的精神病障碍(CIPD)诊断和 104 名首发精神病障碍患者。使用接收者操作特征曲线,对 CIPD 进行分类的最有效的精神病理学变量是人际敏感、“抑郁”、恐惧症焦虑和精神障碍未察觉量表的子量表。包括抑郁和“归因错误”评分的模型的接收者操作特征曲线下面积为 96.78%(95%置信区间,94.43-99.13)。抑郁症状可用于区分 CIPD 和其他首发精神病障碍。与“神经质”症状相关的临床变量可能与大麻引起的精神病易感性有关。